Mammalian Target of Rapamycin Inhibitors, Pipeline Insights, 2016; New Report Launched
Mammalian target of rapamycin (mTOR) inhibitors -Pipeline Insights, 2016 report provides comprehensive insights about pipeline drugs accross this mechanism of action. Key objective of the report is to establish the understanding for all the pipeline drugs that fall under Mammalian target of rapamycin (mTOR) inhibitors. The Report gives insights on 20+ products, 18+ companies that are active in this field and 5 different technologies used in the pipeline.
View full press release